SecBot SecBot
PRESS-RELEASE ·Filed Nov 16, 2026

DARE

Daré Bioscience, Inc.
NEUTRAL
Impact 4/10
Processed5h 25m ago Wirepress-3404084
Press release · Earnings

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3404084

Track record

25 reports on DARE

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +27.03% at T+60 after the Mar 12, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Neutral 4/10 Viewing Entry $0.5959 Now $0.6570 +10.25% settles Feb 16
  2. Oct 27, 202620d ago DEFA14A Bearish 6/10 Entry $0.6800 Now $0.6570 +3.38% settles Jan 26
  3. Oct 6, 20265w ago DEF 14A Bearish 6/10 Entry $0.7900 Now $0.6570 +16.84% settles Jan 4
  4. Oct 1, 20266w ago 8-K Neutral 2/10 Entry $0.8510 Now $0.6570 −22.80% settles Dec 28
  5. Sep 9, 20269w ago 8-K Neutral 2/10 Entry $0.7166 Now $0.6570 −8.32% settles Dec 3
  6. Sep 4, 202610w ago EFFECT Bearish 4/10 Entry $0.7210 Now $0.6570 +8.88% settles Dec 1
  7. Aug 17, 202613w ago 8-K Bearish 7/10 Entry $0.8102 to $0.6921 Now $0.6570 +18.91% ▲ +14.58% +11.63% vs SPY
  8. Aug 17, 202613w ago 424B5 Bearish 7/10 Entry $0.8102 to $0.6921 Now $0.6570 +18.91% ▲ +14.58% +11.63% vs SPY
  9. Aug 13, 202613w ago 8-K Mixed 5/10 Entry $0.9300 to $0.6800 Now $0.6570 −29.35% ▼ −26.88% −23.84% vs SPY
  10. Aug 6, 202614w ago Press Release Neutral 1/10 Entry $1.33 to $0.6820 Now $0.6570 −50.60% ▼ −48.72% −47.30% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (12h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026

Fresh DARE Intelligence

Analysis is for subscribers only.

Subscribe for Full Access